- Home
- Shop
- New Categories
- New Blog
- Contact Us
- Cart
- Login
- Register
Product details
Catalog number BNUB0294-500
Price for BNUB0294-500
Size / count 1x 500 µL
Expression of NKX2.2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2.2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be differentially upregulated in Ewing sarcoma on the basis of array-based gene expression analysis. It acts as a valuable marker for Ewing sarcoma, with a sensitivity of 93% and a specificity of 89%, and aids in the differential diagnosis of small round cell tumors.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for NKX2.2 (NX2/294), 0.2mg/mL is BNUB0294-500.
NKX2.2 (NX2/294), 0.2mg/mL is available in the following size(s): 1x 500 µL.
NKX2.2 (NX2/294), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
NKX2.2 (NX2/294), 0.2mg/mL is manufactured by Biotium.
Estimated delivery time for NKX2.2 (NX2/294), 0.2mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for NKX2.2 (NX2/294), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029a061270361e101653/msds/bnub0294-500.pdf.
Expression of NKX2.2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2.2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be diff
Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.
